Kala-azar-new developments in diagnosis and treatment-Reference-Cited by-同舟云学术

Kala-azar-new developments in diagnosis and treatment

Published:1999-01 Issue:1 Volume:66 Page:63-71
ISSN:0019-5456
Container-title:The Indian Journal of Pediatrics
language:en
Short-container-title:Indian J Pediatr

Author:

Aggarwal Praveen,Handa Rohini,Singh Sarman,Wali Jyoti Prakash

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/BF02752355.pdf

Reference28 articles.

1. Kager PA. Visceral lesihmaniasis.Curr Opinions Infect Dis 1988; 1: 700–703.

2. Allain DS, Kagan IG. A direct agglutination test for leishmaniasis.Am J Trop Med Hyg 1975; 24: 232–236.

3. Harith AE, Kolk AH, Leewenburg Jet al. Improvement of a direct agglutination test for field studies of visceral leishmaniasis.J Clin Immunol 1988; 26: 1321–1325.

4. Singla N, Singh S, Sunder S, Vinayak VK. Evaluation of the direct agglutination test as an immunodiagnostic tool for kalaazar in India.Trans R Soc Trop Med Hyg 1993; 87: 276–279.

5. Singh S, Gilman-Sachs A, Chang KP, Reed SG. Diagnostic and prognostic value of k39 recombinant antigen in Indian leishmaniasis.J Parasitol 1995; 81: 1000–1003.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica;BMC Pharmacology and Toxicology;2021-11-16

Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture

;Drug Design, Development and Therapy;2020-03

3. Identification of Leishmania donovani inhibitors from pathogen box compounds of Medicine for Malaria Venture;2019-07-26

4. Antimony and antimonials;Meyler's Side Effects of Drugs;2016

5. Introduction;SpringerBriefs in Immunology;2013